Companies included in IBB Page 3
This is IBB's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 201–258 of 258.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | 460,056 | NS | 0.030472% |
| PRME | Prime Medicine, Inc. | 704,092 | NS | 0.030165% |
| KROS | Keros Therapeutics, Inc. | 214,789 | NS | 0.029193% |
| FLGT | Fulgent Genetics, Inc. | 148,748 | NS | 0.029117% |
| TECX | Tectonic Therapeutic, Inc. | 75,889 | NS | 0.028879% |
| AURA | Aura Biosciences, Inc. | 338,128 | NS | 0.027849% |
| KYTX | Kyverna Therapeutics, Inc. | 251,263 | NS | 0.026696% |
| MRVI | Maravai LifeSciences Holdings, Inc. | 759,052 | NS | 0.026446% |
| IMRX | Immuneering Corp. | 390,008 | NS | 0.025304% |
| AVXL | Anavex Life Sciences Corp. | 668,447 | NS | 0.025264% |
| TRDA | Entrada Therapeutics, Inc. | 158,267 | NS | 0.02459% |
| Ginkgo Bioworks Holdings, Inc. | Ginkgo Bioworks Holdings, Inc. | 317,323 | NS | 0.023948% |
| UPB | Upstream Bio, Inc. | 213,032 | NS | 0.023604% |
| NGNE | Neurogene, Inc. | 94,694 | NS | 0.023503% |
| LENZ | LENZ Therapeutics, Inc. | 206,971 | NS | 0.023315% |
| AUTL | Autolus Therapeutics plc | 1,321,681 | NS | 0.022455% |
| EDIT | Editas Medicine, Inc. | 731,163 | NS | 0.022234% |
| CABA | Cabaletta Bio, Inc. | 633,353 | NS | 0.020975% |
| CCCC | C4 Therapeutics, Inc. | 608,839 | NS | 0.019713% |
| LRMR | Larimar Therapeutics, Inc. | 350,415 | NS | 0.019413% |
| CADL | Candel Therapeutics, Inc. | 294,995 | NS | 0.017796% |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 186,967 | NS | 0.01777% |
| OmniAb, Inc. | OmniAb, Inc. | 874,147 | NS | 0.016896% |
| NBP | NovaBridge Biosciences | 539,518 | NS | 0.01634% |
| VYGR | Voyager Therapeutics, Inc. | 329,043 | NS | 0.015637% |
| ACIU | AC Immune SA | 443,438 | NS | 0.015013% |
| BCYC | Bicycle Therapeutics plc | 244,101 | NS | 0.013944% |
| CRBU | Caribou Biosciences, Inc. | 594,484 | NS | 0.013906% |
| CDXS | Codexis, Inc. | 683,417 | NS | 0.013714% |
| LYEL | Lyell Immunopharma, Inc. | 54,413 | NS | 0.013438% |
| Cellectis SA | Cellectis SA | 339,873 | NS | 0.013264% |
| FHTX | Foghorn Therapeutics, Inc. | 223,190 | NS | 0.013134% |
| QTRX | Quanterix Corp. | 284,827 | NS | 0.012343% |
| SGMT | Sagimet Biosciences, Inc. | 189,187 | NS | 0.01217% |
| Quantum-Si, Inc. | Quantum-Si, Inc. | 1,223,534 | NS | 0.011659% |
| Silence Therapeutics plc | Silence Therapeutics plc | 173,313 | NS | 0.011245% |
| TNYA | Tenaya Therapeutics, Inc. | 1,200,002 | NS | 0.010229% |
| NMRA | Neumora Therapeutics, Inc. | 421,430 | NS | 0.010117% |
| PEPG | PepGen, Inc. | 451,333 | NS | 0.009835% |
| Humacyte, Inc. | Humacyte, Inc. | 1,222,120 | NS | 0.009128% |
| BDTX | Black Diamond Therapeutics, Inc. | 321,542 | NS | 0.008432% |
| PYXS | Pyxis Oncology, Inc. | 345,130 | NS | 0.006204% |
| GOSS | Gossamer Bio, Inc. | 1,510,536 | NS | 0.006109% |
| MENS | Jyong Biotech Ltd. | 206,499 | NS | 0.005466% |
| Akero Therapeutics, Inc. | Akero Therapeutics, Inc. | 515,954 | NS | 0.004192% |
| AARD | Aardvark Therapeutics, Inc. | 89,682 | NS | 0.004162% |
| Immutep Ltd. | Immutep Ltd. | 809,244 | NS | 0.003497% |
| TKNO | Alpha Teknova, Inc. | 79,636 | NS | 0.002833% |
| N/A | N/A | 33 | NC | 0.000695% |
| Contra Chinook Therape | Contra Chinook Therape | 320,962 | NS | 0.000672% |
| RNAC | Cartesian Therapeutics, Inc. | 6,098 | NS | 0.00002% |
| Fusion Pharmaceuticals, Inc. | Fusion Pharmaceuticals, Inc. | 1,880 | NS | 0.000013% |
| Cargo Therapeutics, Inc. | Cargo Therapeutics, Inc. | 198,104 | NS | 0% |
| Akouos, Inc. | Akouos, Inc. | 157,087 | NS | 0% |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc. | 134,478 | NS | 0% |
| OmniAb Operations, Inc. | OmniAb Operations, Inc. | 46,839 | NS | 0% |
| OmniAb, Inc. | OmniAb, Inc. | 46,839 | NS | 0% |
| N/A | N/A | 53 | NC | -0.000908% |
SEC N-PORT snapshot as of .